Blood · 1997 · 239 citations · 42 references
MedicineGeneticsHematologyHemostasisHuman GeneticsMedical GeneticsDeep Vein ThrombosisThromboembolic DiseaseThrombosisThrombotic DisordersVenous DiseaseVenous ThromboembolismGenetic ThrombophiliaProthrombin Gene MutationSingle Origin HypothesisThrombosis MechanismsThrombosis PathophysiologyThrombotic Risk AssessmentVenous Thromboembolism Epidemiology
A common genetic risk factor for venous thrombosis among Caucasoid subpopulations is a polymorphism, nt G1691A, in blood coagulation factor V that replaces Arg506 with Gln and imparts resistance of factor Va to the anticoagulant, activated protein C. Haplotype analyses using six dimorphic sites in the factor V gene for 117 Caucasian subjects of Jewish, Arab, Austrian, and French origin who were homozygous for nt A1691 compared with 167 controls (nt G1691) support a single origin for this polymorphism. The nt G1691A mutation is estimated to have arisen circa 21,000 to 34,000 years ago, ie, after the evolutionary divergence of Africans from non-Africans and of Caucasoid from Mongoloid subpopulations.
42
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences · 1993 · 2K citations
African Populations and the Evolution of Human Mitochondrial DNA
Linda Vigilant, Mark Stoneking, Henry Harpending et al. · Science · 1991 · 1.4K citations
Ted Koster, FR Rosendaal, Hans de Ronde et al. · The Lancet · 1993 · 1.3K citations
Medicine, Hematology, Hemostasis +14
World distribution of factor V Leiden
David C. Rees, Michael J. Cox, J. B. Clegg · The Lancet · 1995 · 1.2K citations